A Safety Study of SGN-CD123A in Patients With Acute Myeloid Leukemia
Clinical trial NCT02848248 · TERMINATED
Trial details
- NCT number
- NCT02848248
- Sponsor
- Seagen Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2018-04-06
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.